High-sensitivity versus conventional troponin for management and prognosis assessment of patients with acute chest pain

Heart

Volumn 100, Issue 20, 2014, Pages 1591-1596

  Sanchis, Juan ^a   García Blas, Sergio ^a   Mainar, Luis ^a   Mollar, Anna ^a   Abellán, Lidia ^a   Ventura, Silvia ^a   Bonanad, Clara ^a   Consuegra Sánchez, Luciano ^b   Roqué, Mercé ^c   Chorro, Francisco J ^a   Núñez, Eduardo ^a   Núñez, Julio ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b University Hospital Santa Lucia   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; ENOXAPARIN; HIGH SENSITIVITY TROPONIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TROPONIN; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; EMERGENCY WARD; FEMALE; HEART DEATH; HEART DISEASE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HOSPITAL POLICY; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PROGNOSIS; PROPENSITY SCORE; PROSPECTIVE STUDY; RISK ASSESSMENT; THORAX PAIN; UNSTABLE ANGINA PECTORIS; ACUTE DISEASE; BLOOD; CHEST PAIN; COMPARATIVE STUDY; SENSITIVITY AND SPECIFICITY;

ACUTE DISEASE; AGED; CHEST PAIN; FEMALE; HUMANS; MALE; PROGNOSIS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TROPONIN;

EID: 84907274541     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2013-305440     Document Type: Article

References (28)

1. Hamm ChW, Bassand JP, Agewall St, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2011;32:2999-3054.
2. Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. J Am Coll Cardiol 2012;60:1581-98.
3. Apple FS, Collinson PO. Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem 2012;58:54-61.
4. Jaffe A, Ordonez-Llanos J. High-sensitivity cardiac troponin: from theory to clinical practice. Rev Esp Cardiol. 2013;66:687-91.
5. Bonaca MD, Scirica B, Sabatine M, et al. Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay for cardiac troponin I. J Am Coll Cardiol 2010;55:2118-24.
6. Sanchis J, Bardají A, Bosch X, et al. Usefulness of high-sensitivity troponin T for the evaluation of patients with acute chest pain and no or minimal myocardial damage. Am Heart J 2012;164:194-200.
7. Sanchis J, Bardají A, Bosch X, et al. N-terminal pro-brain natriuretic peptide and high-sensitivity troponin in the evaluation of acute chest pain of uncertain etiology. A PITAGORAS substudy. Rev Esp Cardiol 2013;66:532-8.
8. Reichlin T, Hochholzer W, Bassetti St, et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Eng J Med 2009;361:858-67.
9. Keller T, Zeller T, Peetz D, et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Eng J Med 2009;361:858-68-77.
10. Keller T, Zeller T, Ojeda F, et al. Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. JAMA 2011;306:2684-93.
11. Mills NL, Churchhouse A, Lee KK, et al. Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome. JAMA 2011;305:1210-16.
12. Sanchis J, Bodi V, Nuñez J, et al. New risk score for patients with acute chest pain, non-ST-segment deviation and normal troponin concentrations. A comparison with the TIMI risk score. J Am Coll Cardiol 2005;46:443-9.
13. Sanchis J, Bodí V, Núñez J, et al. Usefulness of early exercise testing and clinical risk score for prognostic evaluation in chest pain units without preexisting evidence of myocardial ischemia. Am J Cardiol 2006;97:633-5.
14. Sanchis J, Bodí V, Núñez J, et al. Identification of very low risk chest pain using clinical data in the emergency department. Int J Cardiol 2011;150:260-3.
15. Lee BK, Lessler J, Stuart EA. Improving propensity score weighting using machine learning. Stat Med. 2010;29:337-46.
16. Ridgeway G, McCarey D, Grin BA, et al. Twang: Toolkit for weighting and analysis of non-equivalent groups. 2006. http://cran.fyxm.net/web/packages/twang/
17. Royston P, Parmar MK. Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects. Stat Med 2002;21:2175-97.
18. Jeetley P, Burden L, Stoykova B, et al. Clinical and economic impact of stress echocardiography compared with exercise electrocardiography in patients with suspected acute coronary syndrome but negative troponin: a prospective randomized controlled study. Eur Heart J 2007;28:204-11.
19. Bodi V, Sanchis J, Lopez-Lereu MP, et al. Prognostic and therapeutics implications of dypiridamole stres cardiovascular magnetic resonance on the basis of the ischemic cascade. Heart 2009;95:49-56.
20. Hulten E, Pickett Ch, Bittencourt MS, et al. Outcomes after coronary computed tomography angiography in the emergency department. A systematic review and meta-analysis of randomized, controlled trials. J Am Coll Cardiol 2013;61: 880-92.
21. Morrow DA, Bonaca MP. Real-world application of "delta" troponin. Diagnostic and prognostic implications. J Am Coll Cardiol 2013;62:1239-41.
22. Bjurman Ch, Larsson M, Johanson P, et al. Small changes in troponin T levels are common in patients with non-ST-segment elevation myocardial infarction and are linked to higher mortality. J Am Coll Cardiol 2013;62:1231-8.
23. Reiter M, Twerenbold R, Reichlin T, et al. Early diagnosis of acute myocardial infarction in the elderly using more sensitive cardiac troponin assays. Eur Heart J 2011;32:1379-89.
24. Mingels A, Jacobs L, Michielsen E, et al. Reference population and marathon runner sera assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and I assays. Clin Chem 2009;55:101-8.
25. Apple FS, Murakami MAM, Pearce LA, et al. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation 2002;106:2941-5.
26. Reiter M, Twerenbold R, Reichlin T, et al. Early diagnosis of acute myocardial infarction I patients with pre-existing coronary artery disease using more sensitive cardiac troponin assays. Eur Heart J 2012;33:988-97.
27. Newby KL, Jesse RL, Gersh BJ, et al. ACCF 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations. J Am Coll Cardiol 2012;60:2427-63.
28. Sanchis J, Bodí V, Núñez J, et al. Efficacy of coronary revascularization in patients with acute chest pain managed in chest pain unit. Mayo Clin Proc 2009;84:323-9.